Tirzepatide (GLP-TZ) Research Peptide – 10 mg

Tirzepatide, identified in our catalog as GLP-TZ, is a synthetic dual-receptor research peptide supplied in a 10 mg vial for controlled laboratory, analytical, and scientific investigations.

Tirzepatide is characterized by agonist activity at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. This dual-receptor profile makes the compound relevant to laboratory investigations involving incretin signaling, receptor interactions, metabolic pathways, and comparative peptide research.

This product is supplied exclusively as research material. It is not intended for human consumption, veterinary administration, diagnosis, or medical treatment.

Product Specifications

• Full compound name: Tirzepatide
• Catalog identifier: GLP-TZ
• Strength: 10 mg per vial
• Compound category: Dual-receptor incretin research peptide
• Receptor profile: GIP and GLP-1 receptors
• Documentation: Certificate of Analysis available
• Available quantities: 1, 3, 5, 10, or 20 vials
• Shipping origin: United States
• Delivery: Domestic US-to-US shipping
• Intended purpose: Laboratory research and analytical testing only

Tirzepatide Research Characteristics

Tirzepatide is studied for its activity across two incretin-related receptor systems: GIPR and GLP-1R.

Its dual-receptor profile provides researchers with a compound suitable for investigations examining the interaction between multiple incretin signaling pathways and for comparisons with single- and multi-receptor research compounds.

Potential areas of laboratory investigation include:

• GIP receptor signaling
• GLP-1 receptor signaling
• Dual-receptor agonism
• Incretin-related signaling pathways
• Receptor-binding investigations
• Peptide-receptor interaction studies
• Metabolic signaling research
• Comparative peptide analysis
• Compound characterization
• Analytical testing
• Stability and degradation studies
• Research method development

References to these pathways describe areas of scientific investigation only. They should not be interpreted as therapeutic, medical, weight-management, or personal-use claims for this research material.

Dual GIP and GLP-1 Receptor Research

One of the principal characteristics of Tirzepatide is its activity at two distinct receptor systems.

GIP receptor (GIPR): GIP is an incretin-related signaling molecule, and its receptor is investigated in studies examining endocrine and metabolic signaling pathways.

GLP-1 receptor (GLP-1R): GLP-1 receptor signaling is extensively investigated in metabolic, endocrine, and incretin-related research.

The ability to investigate both receptor pathways using a single research compound makes Tirzepatide particularly relevant for comparative receptor-signaling studies.

COA-Confirmed Research Material

Tirzepatide (GLP-TZ) Research Peptide – 10 mg is supplied with access to batch-specific Certificate of Analysis (COA) documentation.

Depending on the analytical testing performed for the applicable batch, documentation may contain information such as:

• Compound identity
• Batch or lot number
• Tested purity
• Analytical testing methodology
• Laboratory test date
• Reported analytical results

Researchers should review the applicable Certificate of Analysis before beginning an experiment.

The batch-specific COA should be considered the controlling source for exact specifications and analytical results associated with an individual lot.

Available Multi-Vial Options

Tirzepatide GLP-TZ 10 mg is available in several quantity options to accommodate individual experiments and larger laboratory requirements:

• 1 Vial – Regular Price
• 3 Vials – 5% OFF
• 5 Vials – 10% OFF ★ Most Popular ★
• 10 Vials – 15% OFF
• 20 Vials – 20% OFF

Each vial contains 10 mg of Tirzepatide research peptide.

Multi-vial packages provide a lower effective price per vial and may be useful for projects requiring multiple samples, comparative testing, repeated analytical work, or larger quantities of material.

Storage and Laboratory Handling

Store Tirzepatide according to the conditions specified on the product label, packaging, and applicable batch documentation.

General laboratory precautions include:

• Keep the vial securely sealed until required
• Protect the material from excessive heat and direct light
• Avoid unnecessary temperature fluctuations
• Protect the material from moisture and contamination
• Use clean laboratory equipment and appropriate handling procedures
• Maintain accurate batch and lot records
• Record storage conditions and handling history
• Follow batch-specific storage requirements
• Minimize unnecessary handling of the research material

Exact storage requirements should always be confirmed using the product label and documentation supplied with the applicable batch.

Laboratory Use and Research Responsibility

Tirzepatide GLP-TZ 10 mg should be handled by qualified individuals familiar with laboratory procedures and research peptide management.

The purchaser is responsible for ensuring appropriate acquisition, storage, handling, documentation, experimental use, and disposal in accordance with applicable regulations and institutional requirements.

BuyGenerics does not provide personal administration instructions, dosage recommendations, clinical treatment protocols, or therapeutic guidance for this research product.

Domestic US Shipping

Tirzepatide (GLP-TZ) Research Peptide – 10 mg is available with domestic US-to-US fulfillment.

Ordering benefits include:

• Fast domestic delivery
• No international customs processing
• Discreet packaging
• Secure online ordering
• Tracked shipping options
• Single-vial and bulk packages
• Quantity discounts of up to 20%

Shipping availability and delivery times may vary depending on destination, inventory availability, order size, and selected delivery service.

Frequently Asked Questions

How much Tirzepatide is contained in each vial?

Each vial contains 10 mg of Tirzepatide (GLP-TZ) research peptide.

What does GLP-TZ mean?

GLP-TZ is the catalog identifier used for Tirzepatide within this research product range.

What receptors are associated with Tirzepatide research?

Tirzepatide is studied as a dual-receptor agonist with activity at the GIP and GLP-1 receptors.

Is a Certificate of Analysis available?

Yes. Batch-specific Certificate of Analysis documentation is available. Researchers should consult the applicable COA for exact analytical specifications and reported test results.

Can I purchase multiple vials?

Yes. Available package quantities include 1, 3, 5, 10, and 20 vials, with increasing quantity discounts.

Does BuyGenerics ship domestically within the United States?

Yes. This product is offered with domestic US-to-US fulfillment, subject to inventory availability and destination.

Is Tirzepatide GLP-TZ 10 mg intended for human use?

No. This product is sold exclusively for laboratory research and analytical applications and is not intended for human consumption or administration.

Research-Use Disclaimer

Tirzepatide (GLP-TZ) Research Peptide – 10 mg is intended exclusively for laboratory research, analytical testing, and scientific investigation.

This product is:

• Not for human consumption
• Not for human administration
• Not for veterinary use
• Not a dietary supplement
• Not supplied as a prescription medication
• Not intended to diagnose, treat, cure, or prevent disease
• Not intended for household or recreational use

Information presented on this product page is provided solely for product identification and research-catalog purposes. It does not constitute medical advice, prescribing information, dosage guidance, or instructions for administration.